BioWorld

May 10, 2002

Bush's Zerhouni Confirmed By Senate As NIH Director

WASHINGTON - President Bush's choice as director of the National Institutes of Health won Senate confirmation, just in time to enter the pending debate on Capitol Hill concerning therapeutic cloning. (BioWorld Today) Read More

Onyx Placement Gets $20M To Pursue Anticancer Drugs

Merck Scientists' Compound Pinpoints B. anthracis Lethal Toxin As Antibiotics Adjunct

Genome Canada Supporting National Genomics Research

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 12, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Illustration of head with maze that is missing parts

CTAD 2025: The challenges of combination therapies for dementia

BioWorld Science

At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...

DEE-lightful: Praxis’ phase II results allow stock to flex its muscle

BioWorld

Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...